FOR RESEARCH PURPOSES ONLY
IGF-1 LR3 1mg research grade peptide- Pure Performance Labs

IGF-1 LR3

Research Grade Peptide
  • Research Grade
  • 99% Purity
  • Third-Party Verified
Reference Strength: 1mg
R1399,00

Availability: In stock

SKU: IG1
,

IGF-1 LR3

R1399,00

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified analog of human IGF-1 widely researched for its potential role in anabolic signalling, recovery support, tissue repair, cellular growth and metabolic function. It is studied for its extended half-life and enhanced bioavailability compared with native IGF-1. 

Availability: In stock

Included with your purchase Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.

Peptide Calculator

Quickly calculate your reconstitution values.

Open Calculator

Research Overview

About IGF-1 LR3

IGF-1 LR3 is a synthetic modified version of insulin-like growth factor-1 designed to remain active for longer than native IGF-1.

How It Works in Research

Researchers investigate IGF-1 LR3 for its ability to bind IGF-1 receptors and support anabolic signalling, protein synthesis, recovery pathways and metabolic regulation.

Research Applications

Muscle-growth research Recovery and repair investigations Tissue-support studies Metabolic-function research Performance and body-composition studies Growth-factor pathway research

This is a simplified explanation for educational purposes. For detailed scientific information, see the Product Specifications section below.

Functional Performance Profile

Muscle Growth Research
Recovery & Repair Research
Metabolic Support Research

Key Benefits

  • Studied for anabolic signalling research
  • Investigated for muscle-growth pathways
  • Researched for recovery and tissue-repair support
  • Investigated for metabolic-function applications
  • Studied for extended IGF-1 receptor activity
  • Popular in performance and body-composition research

Product Specifications

  • Product Name: IGF-1 LR3
  • Alternate Name: Long R3 Insulin-like Growth Factor-1
  • Strength: 1mg
  • Purity Standard: ≥99%

Research Information

  • Appearance: Lyophilised Powder
  • Category: Growth Factor Research Peptide
  • Storage: Refrigerate After Reconstitution

Research Reference Parameters — Laboratory Use Only

  • Peptide Type: IGF-1 Analog
  • Research Focus: Growth, Recovery & Metabolic Research
  • Primary Pathway: IGF-1 Receptor Activation
  • Investigated Areas: Anabolic Signalling, Recovery, Tissue Repair, Metabolic Function
  • Research Status: Experimental Research Compound
For laboratory research only.

Mechanism of Action

IGF-1 LR3 is researched as a modified analog of human IGF-1 engineered for reduced binding to IGF-binding proteins. This modification may extend its activity and increase systemic bioavailability compared with native IGF-1. Researchers investigate IGF-1 LR3 for its potential influence on IGF-1 receptor activation, anabolic signalling, cellular growth pathways, protein synthesis, nutrient utilisation and metabolic regulation.

Key Research Characteristics

Modified IGF-1 analog

Extended half-life research compound Reduced binding to IGF-binding proteins Enhanced bioavailability investigations IGF-1 receptor activation research Anabolic-signalling research Recovery and tissue-support studies

Potential Benefits in Research

Enhanced anabolic signalling research

  • Protein-synthesis investigations
  • Muscle-growth pathway research
  • Recovery and repair studies
  • Tissue-support research
  • Metabolic-function investigations
  • Body-composition studies
  • Nutrient-utilisation research
  • Growth-factor signalling studies
  • Cellular-growth pathway research
  • Extended bioavailability compared with native IGF-1
  • IGF-1 receptor activation research

Safety Profile

Hypoglycaemia or low blood sugar symptoms

  • Dizziness or light-headedness
  • Shakiness or sweating
  • Increased hunger
  • Mild headache
  • Temporary fatigue
  • Injection-site irritation
  • Localised redness or discomfort
  • Individual variability in response
  • Increased risk with higher dosing ranges
  • Blood-glucose fluctuations may occur
  • Conservative dosing is recommended
  • Research-use compound with no approved therapeutic use

Research Applications

Muscle-growth research
Recovery and repair investigations
Tissue-regeneration studies
Metabolic-function research
Body-composition investigations
Performance-research protocols
Growth-factor pathway studies
Research Note: The information presented here is based on published scientific literature and research protocols. Individual results may vary based on research design, subject characteristics, and methodological approaches. Always conduct appropriate due diligence and follow institutional research guidelines. IGF-1 LR3 is one of the most widely researched growth-factor peptides due to its extended half-life and enhanced systemic bioavailability compared with native IGF-1. It remains a research-use compound and is not approved for human therapeutic use.

REFERENCE RECONSTITUTION INFORMATION

This guide explains how research peptides are commonly reconstituted using bacteriostatic water (BAC water), and shows how dosing volumes correspond to syringe units. Always follow sterile preparation techniques when handling research peptides.

Always follow sterile preparation techniques when handling research peptides.

⚠️ DISCLAIMER: This guide is for educational purposes only and is not medical advice. For research use only.

General Preparation

⚠️ Important: Allow product vial and BAC water to reach room temperature before reconstituting to reduce condensation uptake
  • Allow vial to reach room temperature before preparation
  • Draw bacteriostatic water using a sterile syringe
  • Inject slowly down the inside wall of the vial
  • Avoid foaming
  • Gently swirl until fully dissolved
  • Do not shake vigorously
  • Label with the reconstitution date
  • Refrigerate at 2°C–8°C
  • Protect from direct light exposure

IGF-1 LR3 (1mg) - RECONSTITUTION TABLES

Reference Handling Information

Reference information for laboratory handling of IGF-1 LR3.

  • Goal: Support Anabolic Signalling, Recovery & Metabolic Research
  • Route: Subcutaneous
  • Schedule: Once Daily
  • Dose Range: 0.02mg – 0.05mg Daily
  • Reconstitution Options: 2ml or 3ml BAC Water
  • Final Concentration (2ml): 0.5mg/ml / 500mcg/ml
  • Final Concentration (3ml): 0.333mg/ml / 333mcg/ml
  • Storage: Refrigerated After Reconstitution

Reference Parameters (Dosing Protocol (2ml Reconstitution))

PhaseDaily DoseUnitsVolume
Weeks 1–20.02mg / 4 Units0.04ml
Weeks 3–40.04mg /8 Units0.08ml
Weeks 5–80.05mg / 10 Units0.10ml
For laboratory research only.

Reference Parameters (Dosing Protocol (3ml Reconstitution))

PhaseDaily DoseUnitsVolume
Weeks 1–20.02mg / 6 Units0.06ml
Weeks 3–40.04mg / 12 Units0.12ml
Weeks 5–80.05mg / 15 Units0.15ml
For laboratory research only.

Experimental Study Period

STUDY PERIOD
8 weeks. Extended cycle: Up to 12 weeks in advanced research settings
WASHOUT PERIOD
4–8 weeks
These tables show common research dosages. Always use an insulin syringe marked with units for accurate measurement. Contact our research support team for additional guidance.
📄

View Certificate of Analysis

View Certificate of Analysis Each batch of IGF-1 LR3 is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.

99.7%
Verified Purity
3rd Party
Lab Tested
Certified
Quality Assured

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

FOR RESEARCH PURPOSES ONLY

This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.

Scroll to Top